These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 32414615

  • 1. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.
    Stenbäck A, Olafsdottir T, Sköldenberg E, Barker G, Stenberg A, Läckgren G.
    J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615
    [Abstract] [Full Text] [Related]

  • 2.
    Lotfollahzadeh S, Leslie SW, Aeddula NR.
    ; 2024 01. PubMed ID: 33085409
    [Abstract] [Full Text] [Related]

  • 3. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
    Chung KLY, Sihoe J, Liu K, Chao N, Hung J, Liu C, Yam F, Leung Y, Tam P, Lee KH, Leung M.
    J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
    [Abstract] [Full Text] [Related]

  • 4. Is routine voiding cystourethrogram necessary following double hit for primary vesicoureteral reflux?
    Arlen AM, Scherz HC, Filimon E, Leong T, Kirsch AJ.
    J Pediatr Urol; 2015 Feb; 11(1):40.e1-5. PubMed ID: 25725613
    [Abstract] [Full Text] [Related]

  • 5. Treatment of vesicoureteral reflux in children using stabilized non-animal hyaluronic acid/dextranomer gel (NASHA/DX): a long-term observational study.
    Stenberg A, Läckgren G.
    J Pediatr Urol; 2007 Apr; 3(2):80-5. PubMed ID: 18947708
    [Abstract] [Full Text] [Related]

  • 6. Endoscopic hyaluronic acid/dextranomer gel implantation is effective as first-line treatment of vesicoureteral reflux (VUR) in children: a single centre experience.
    Häcker FM, Frech-Dörfler M, von Rotz M, Rudin C.
    Eur J Pediatr Surg; 2011 Oct; 21(5):299-303. PubMed ID: 21688236
    [Abstract] [Full Text] [Related]

  • 7. [Dextranomer beads in stabilized non-animal sodium hyaluronate gel (NASHA/Dx gel) for vesicoureteral reflux: multi-center study in Japanease patients].
    Tanikaze S, Osa Y, Tada M, Goya N, Asanuma H, Yamazaki Y, Shimada K, Sugita Y, Goto T, Yamaguchi T.
    Nihon Hinyokika Gakkai Zasshi; 2010 Jul; 101(5):676-82. PubMed ID: 20715499
    [Abstract] [Full Text] [Related]

  • 8. Endoscopic treatment of primary grade V vesicoureteral reflux using hyaluronic acid copolymer (DX/HA).
    Hunziker M, Mohanan N, D'Asta F, Puri P.
    Pediatr Surg Int; 2010 Oct; 26(10):977-9. PubMed ID: 20625750
    [Abstract] [Full Text] [Related]

  • 9. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
    Kirsch AJ, Perez-Brayfield MR, Scherz HC.
    J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
    Dogan HS, Altan M, Citamak B, Bozaci AC, Koni A, Tekgul S.
    J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
    [Abstract] [Full Text] [Related]

  • 11. Intraureteral injection of NASHA/Dx gel under direct ureteroscopic visualization for the treatment of primary high-grade vesicoureteral reflux.
    Mattioli G, Guida E, Rossi V, Podestà E, Jasonni V, Ghiggeri GM.
    J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):844-7. PubMed ID: 22989035
    [Abstract] [Full Text] [Related]

  • 12. What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?
    Chertin B, Mele E, Kocherov S, Zilber S, Gerocarni Nappo S, Capozza N.
    J Pediatr Urol; 2018 Dec; 14(6):538.e1-538.e7. PubMed ID: 29885870
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents.
    Stredele RJ, Dietz HG, Stehr M.
    J Pediatr Urol; 2013 Feb; 9(1):71-6. PubMed ID: 22212178
    [Abstract] [Full Text] [Related]

  • 17. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
    Friedmacher F, Colhoun E, Puri P.
    J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
    [Abstract] [Full Text] [Related]

  • 18. Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population.
    Sheth KR, White JT, Stanasel I, Janzen N, Mittal A, Koh CJ, Austin PF, Roth DR, Tu DD, Gonzales ET, Ryan S, Jorgez C, Seth A.
    J Pediatr Urol; 2018 Dec; 14(6):554.e1-554.e6. PubMed ID: 30146426
    [Abstract] [Full Text] [Related]

  • 19. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
    García-Aparicio L, Blázquez-Gómez E, Martin O, Pérez-Bertólez S, Arboleda J, Soria A, Tarrado X.
    World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806
    [Abstract] [Full Text] [Related]

  • 20. Outcome of salvage ureteral reimplantation after endoscopic treatment failure for high-grade vesicoureteral reflux compared to primary ureteral reimplantation.
    Burki T, Howeiti MS, Almadhi MK, Al Modhen FM, Alhazmi H, Vallasciani SA, Alhams AE, Mehmood SW, Al Shammari AM.
    Urol Ann; 2020 Oct; 12(1):49-53. PubMed ID: 32015617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.